Organoid research has been approved as a key special project of the National Key R&D Program in China’s 14th Five-Year Plan

Release time:

2021-01-01 00:00

Source:

类器官被列为“十四五”国家重点研发计划重点专项；国家药监局药审中心发布《基因修饰细胞治疗产品非临床研究技术指导原则（试行）》，其明确指出，可采用基于细胞和组织的模型（如二维或三维组织模型、类器官和微流体模型等）为有效性和安全性的评估提供有用的补充信息。

Previous Page

The U.S. House of Representatives passed the Food and Drug Amendments of 2022, which includes OoCs and Microphysiological Systems (MPSs) as independent systems for evaluating drugs in non-clinical trials

Southeast University in China developed a bronchial-lung-on-chip that could be used for the evaluation of COVID-19 infections and treatments, and applied it at the Jiangsu Provincial Center for Disease Control and Prevention

Next Page

Previous Page

The U.S. House of Representatives passed the Food and Drug Amendments of 2022, which includes OoCs and Microphysiological Systems (MPSs) as independent systems for evaluating drugs in non-clinical trials

Next Page

Southeast University in China developed a bronchial-lung-on-chip that could be used for the evaluation of COVID-19 infections and treatments, and applied it at the Jiangsu Provincial Center for Disease Control and Prevention

We use optional cookies to improve your experience on our website, including through social media connections, and to personalize ads based on your online activity. If you refuse optional cookies, we will only use cookies that are necessary to provide you with the services.Privacy Statement